back to all entries

Rep. Shontel Brown Introduces ‘HER’ Act to Investigate Chemicals in Beauty Products 

July 02,2025

Rep. Shontel Brown (D-Ohio) has introduced the Health & Endocrine Research on Personal Care Products for Women (HER) Act, a bill aimed at funding research into the link between personal care products and reproductive health issues in Black and Latina women. 

The bill would create a federal grant program to study endocrine-disrupting chemicals found in many beauty and hygiene products marketed to women of color. These chemicals have been linked to serious conditions like uterine fibroids, infertility, and cancer. 

Brown said the HER Act will raise awareness, improve consumer safety, and address racial health disparities. “There is a clear nexus between unsafe products… and the higher incidence of reproductive health issues that we experience,” she said. 

Supporters of the bill include the Endocrine Society and the American Medical Women’s Association, who say the legislation is an important step toward protecting women’s health. 

To read more about the ‘HER’ Act, click here

Other Posts

11/20/25

The Painful Effects of Heavy Periods

It’s Not ‘Just a Period’: The Real Impact of Heavy Bleeding on Daily Life It is incredibly difficult to explain just how debilitating heavy periods are to those who haven’t

11/05/25

The Rise of Minimally Invasive Options for Fibroids

For generations, women, particularly women of color, have suffered in silence with uterine fibroids, enduring debilitating symptoms like heavy bleeding and pain, often being told their condition was “normal.” Today,

Why Are So Many Women With Fibroids Still Getting Hysterectomies?
10/15/25

Why Are So Many Women With Fibroids Still Getting Hysterectomies?

Despite major advances in women’s health, hysterectomy remains the most common surgical treatment for uterine fibroids — even when less invasive, uterus-sparing options are available. According to a recent report